| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.47 | 0.005 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |